发明名称 METHODS FOR IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS RECEIVING CANCER THERAPY
摘要 PROBLEM TO BE SOLVED: To provide identification of predictive markers that can be used to clinically determine whether patients with cancer are responsive or non-responsive to a therapeutic regimen prior to treatment.SOLUTION: In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, where the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers included in a marker set, it is possible to determine whether a therapeutic agent, or a combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.SELECTED DRAWING: None
申请公布号 JP2016101174(A) 申请公布日期 2016.06.02
申请号 JP20160023487 申请日期 2016.02.10
申请人 MILLENNIUM PHARMACEUTICALS INC 发明人 BRYANT BARBARA M;DAMOKOSH ANDREW I;MULLIGAN GEORGE
分类号 C12N15/09;A61P35/02;C12M1/00;C12M1/34;C12Q1/02;C12Q1/04;C12Q1/68;G01N33/53;G01N33/574;G06Q50/00 主分类号 C12N15/09
代理机构 代理人
主权项
地址